HGH Frag 176-191
A fragment of HGH studied specifically for fat loss and lipolysis.
Overview
HGH Frag 176-191 is a synthetic fragment of the human growth hormone molecule, corresponding to the region associated with fat metabolism. Like AOD-9604, it is designed to promote lipolysis (fat burning) while avoiding the broader metabolic effects of full HGH. It is a staple of fat-loss research protocols.
Dosing
Injection
- Starting dose
- 250 mcg
- Common dose
- 250–500 mcg
- Frequency
- 1–2× daily
- Notes
- Often dosed fasted; commonly stacked with GHRPs.
Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.
How it works
HGH Frag 176-191 mimics the lipolytic region of HGH, stimulating the breakdown of stored fat and reducing fat storage without raising blood sugar or promoting growth the way full HGH does. It is often used in cycles around training and fasting.
Common research uses
- Fat metabolism and lipolysis research
- Weight and body-composition protocols
- Cutting-phase research studies
- Metabolic studies alongside HGH research
Considerations
Evidence is largely preclinical and from AOD-9604-related research. Results depend strongly on diet and training. Like all research peptides, purity and handling are critical.